Northland Capmk Brokers Boost Earnings Estimates for Enovix

Enovix Corporation (NASDAQ:ENVX - Free Report) - Northland Capmk upped their Q1 2026 earnings estimates for Enovix in a note issued to investors on Monday, July 7th. Northland Capmk analyst G. Richard now anticipates that the company will post earnings of ($0.20) per share for the quarter, up from their prior forecast of ($0.28). The consensus estimate for Enovix's current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix's Q2 2026 earnings at ($0.21) EPS, Q3 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.21) EPS and FY2026 earnings at ($0.85) EPS.

A number of other equities analysts have also commented on ENVX. Benchmark reduced their price target on shares of Enovix from $25.00 to $15.00 and set a "buy" rating on the stock in a research report on Tuesday, April 15th. TD Cowen upgraded shares of Enovix to a "hold" rating and upped their target price for the stock from $7.00 to $15.00 in a research report on Monday. Craig Hallum reiterated a "buy" rating and set a $15.00 target price (up from $12.00) on shares of Enovix in a research report on Tuesday. B. Riley reiterated a "buy" rating and set a $17.00 target price (up from $12.00) on shares of Enovix in a research report on Thursday. Finally, JPMorgan Chase & Co. dropped their price target on shares of Enovix from $10.00 to $9.00 and set an "overweight" rating for the company in a research note on Thursday, May 1st. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, Enovix has a consensus rating of "Moderate Buy" and an average target price of $17.55.

Enovix Price Performance

NASDAQ ENVX traded down $0.05 on Wednesday, reaching $14.07. The company's stock had a trading volume of 8,396,955 shares, compared to its average volume of 5,966,131. The firm has a market cap of $2.70 billion, a PE ratio of -10.91 and a beta of 2.09. The business has a 50-day moving average price of $8.72 and a 200 day moving average price of $9.07. Enovix has a 52 week low of $5.27 and a 52 week high of $18.68. The company has a current ratio of 4.68, a quick ratio of 4.49 and a debt-to-equity ratio of 0.71.

Institutional Investors Weigh In On Enovix

Several large investors have recently bought and sold shares of the company. Victory Capital Management Inc. increased its stake in Enovix by 6.8% in the fourth quarter. Victory Capital Management Inc. now owns 19,695 shares of the company's stock valued at $214,000 after purchasing an additional 1,257 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Enovix by 6.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 21,413 shares of the company's stock worth $233,000 after purchasing an additional 1,336 shares during the last quarter. Xponance Inc. lifted its stake in Enovix by 17.3% in the fourth quarter. Xponance Inc. now owns 11,810 shares of the company's stock valued at $128,000 after acquiring an additional 1,738 shares during the last quarter. DDD Partners LLC lifted its stake in Enovix by 5.9% in the first quarter. DDD Partners LLC now owns 31,461 shares of the company's stock valued at $231,000 after acquiring an additional 1,764 shares during the last quarter. Finally, Arizona State Retirement System lifted its stake in Enovix by 4.5% in the fourth quarter. Arizona State Retirement System now owns 43,464 shares of the company's stock valued at $472,000 after acquiring an additional 1,856 shares during the last quarter. Institutional investors own 50.92% of the company's stock.

Enovix announced that its Board of Directors has approved a share repurchase plan on Wednesday, July 2nd that permits the company to repurchase $60.00 million in shares. This repurchase authorization permits the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board of directors believes its stock is undervalued.

About Enovix

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.